Federated Hermes’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-246,804
| Closed | -$2.25M | – | 2215 |
|
|
2025
Q2 | $2.25M | Sell |
246,804
-945,685
| -79% | -$6.96M | ﹤0.01% | 909 |
|
|
2025
Q1 | $9.48M | Buy |
1,192,489
+86,710
| +8% | +$635K | 0.02% | 569 |
|
|
2024
Q4 | $6M | Buy |
1,105,779
+430,432
| +64% | +$2.63M | 0.01% | 662 |
|
|
2024
Q3 | $4.88M | Buy |
675,347
+4,879
| +0.7% | +$44.7K | 0.01% | 718 |
|
|
2024
Q2 | $7.28M | Buy |
+670,468
| New | +$8.59M | 0.02% | 621 |
|
|
2024
Q1 | – | Sell |
-534
| Closed | -$11.6K | – | 2113 |
|
|
2023
Q4 | $11.6K | Sell |
534
-165,451
| -100% | -$3.28M | ﹤0.01% | 1783 |
|
|
2023
Q3 | $3.42M | Buy |
+165,985
| New | +$4.79M | 0.01% | 791 |
|
|
2022
Q3 | – | Sell |
-7,584
| Closed | -$245K | – | 2229 |
|
|
2022
Q2 | $245K | Sell |
7,584
-17,780
| -70% | -$596K | ﹤0.01% | 1505 |
|
|
2022
Q1 | $840K | Sell |
25,364
-14,155
| -36% | -$532K | ﹤0.01% | 1304 |
|
|
2021
Q4 | $1.68M | Buy |
39,519
+5,473
| +16% | +$229K | ﹤0.01% | 1100 |
|
|
2021
Q3 | $1.51M | Buy |
34,046
+6,141
| +22% | +$282K | ﹤0.01% | 1132 |
|
|
2021
Q2 | $1.58M | Buy |
27,905
+3,734
| +15% | +$264K | ﹤0.01% | 1166 |
|
|
2021
Q1 | $1.81M | Sell |
24,171
-136,696
| -85% | -$11.2M | ﹤0.01% | 1148 |
|
|
2020
Q4 | $13.9M | Sell |
160,867
-60,175
| -27% | -$4.44M | 0.03% | 557 |
|
|
2020
Q3 | $13.5M | Buy |
221,042
+3,487
| +2% | +$177K | 0.03% | 504 |
|
|
2020
Q2 | $9.05M | Buy |
217,555
+141,313
| +185% | +$5.13M | 0.02% | 570 |
|
|
2020
Q1 | $2.19M | Buy |
+76,242
| New | +$4.41M | 0.01% | 864 |
|
|
2019
Q3 | – | Sell |
-4,830
| Closed | -$884K | – | 2285 |
|
|
2019
Q2 | $884K | Buy |
+4,830
| New | +$824K | ﹤0.01% | 1323 |
|
|
2018
Q3 | – | Sell |
-5,399
| Closed | -$845K | – | 2317 |
|
|
2018
Q2 | $845K | Sell |
5,399
-28,271
| -84% | -$4.44M | ﹤0.01% | 1337 |
|
|
2018
Q1 | $5.42M | Buy |
33,670
+23,316
| +225% | +$3.96M | 0.02% | 598 |
|
|
2017
Q4 | $1.71M | Sell |
10,354
-742,203
| -99% | -$72M | ﹤0.01% | 996 |
|
|
2017
Q3 | $46.9M | Sell |
752,557
-136,234
| -15% | -$10.7M | 0.13% | 132 |
|
|
2017
Q2 | $70.8M | Sell |
888,791
-71,909
| -7% | -$5.2M | 0.2% | 98 |
|
|
2017
Q1 | $68.3M | Buy |
960,700
+900
| +0.1% | +$52.7K | 0.19% | 99 |
|
|
2016
Q4 | $49M | Sell |
959,800
-264,400
| -22% | -$12.5M | 0.15% | 132 |
|
|
2016
Q3 | $56.4M | Buy |
1,224,200
+929,200
| +315% | +$37.8M | 0.16% | 114 |
|
|
2016
Q2 | $8.89M | Buy |
295,000
+50,000
| +20% | +$1.67M | 0.03% | 440 |
|
|
2016
Q1 | $7.86M | Buy |
245,000
+40,000
| +20% | +$1.41M | 0.02% | 462 |
|
|
2015
Q4 | $12M | Buy |
205,000
+300
| +0.1% | +$14.9K | 0.04% | 402 |
|
|
2015
Q3 | $8.66M | Buy |
204,700
+500
| +0.2% | +$30.8K | 0.03% | 463 |
|
|
2015
Q2 | $14.9M | Hold |
204,200
| – | – | 0.04% | 385 |
|
|
2015
Q1 | $10.3M | Hold |
204,200
| – | – | 0.03% | 456 |
|
|
2014
Q4 | $7.47M | Hold |
204,200
| – | – | 0.02% | 518 |
|
|
2014
Q3 | $6.43M | Buy |
+204,200
| New | +$5.92M | 0.02% | 561 |
|
Other funds holding SAGE
IA
HNB
Federated Hermes's SAGE Position: Q3 2025 in Review
Federated Hermes sold out of Sage Therapeutics (SAGE) in Q3 2025, closing a stake of 246,804 shares — an estimated $2.25M sold.
Federated Hermes first reported a position in SAGE in Q3 2014 and held it in 34 quarters. The position peaked at $70.8M in Q2 2017. 5 funds tracked by Wall St. Rank hold SAGE as of Q3 2025.
- Federated Hermes reported no remaining Sage Therapeutics position as of Q3 2025 after selling out during the quarter.
- Federated Hermes sold 246,804 Sage Therapeutics shares in Q3 2025, an estimated $2.25M.
- Federated Hermes first reported a position in Sage Therapeutics in Q3 2014 and held it in 34 quarters.
- Federated Hermes's Sage Therapeutics position peaked at $70.8M in Q2 2017.
- 5 funds tracked by Wall St. Rank held Sage Therapeutics as of Q3 2025.
Based on Federated Hermes's 13F filing for Q3 2025, filed 3 Nov 2025.